Optimal management of ALK-positive NSCLC progressing on crizotinib

Giulio Metro, Marco Tazza, Roberta Matocci, Rita Chiari, Lucio Crinò

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Optimal management of ALK-positive NSCLC progressing on crizotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences